Substantial basic science and clinical evidence suggests that excess tumor necrosis factor-alpha (TNF-alpha) is centrally involved in the pathogenesis of Alzheimer's disease. In addition to its ...

If you have certain types of arthritis or plaque psoriasis, your doctor may prescribe Enbrel. It’s used to treat the following conditions: Enbrel contains the active drug etanercept, which is a ...

Please provide your email address to receive an email when new articles are posted on . Approximately 70% of patients with juvenile idiopathic arthritis who are re-treated with etanercept achieve ...

THOUSAND OAKS, Calif. and NEW YORK, May 25, 2011 /PRNewswire/ -- Amgen (NASDAQ: AMGN) and Pfizer Inc. (NYSE: PFE) today announced new results from multiple studies of ENBREL, further expanding the ...

Please provide your email address to receive an email when new articles are posted on . Originator- and biosimilar-receiving patients with rheumatoid arthritis demonstrated similar disease activity at ...

In the absence of much federal action, states have enacted dozens of laws this year to lower prescription drug costs for their residents—and many more are considering following suit. The first ...

The government of Australia’s pricing policy links the price of new medications with similar safety and efficacy, resulting in significant savings over the first 3 years after the etanercept ...

Drug treatment of rheumatoid arthritis aims to reduce inflammation, which slows the progression of joint damage. Etanercept is a soluble tumor necrosis factor (TNF) receptor that mops up circulating ...

An Unusual Case of Renal Cell Carcinoma Metastasis to Duodenum Presenting as Gastrointestinal Bleeding A 2017 literature review of all available cases of pneumonitis attributed to FOLFOX (oxaliplatin ...

In real-world settings, new initiators of targeted therapies for psoriatic arthritis experienced a low incidence of serious infection, with a lower risk observed among those starting etanercept and ...

Real-world data suggest anti-TNF biosimilars for juvenile idiopathic arthritis offer comparable efficacy and safety to their brand name counterparts. As high-cost originator biologics continue to ...